A Multicenter, Single-Arm Study of the Effects of Atrasentan on Spermatogenesis and Testicular Function
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 27 Nov 2017
At a glance
- Drugs Atrasentan (Primary)
- Indications Diabetic nephropathies
- Focus Pharmacodynamics
- Sponsors AbbVie
- 21 Nov 2017 Status changed from recruiting to active, no longer recruiting.
- 03 Feb 2016 Planned End Date changed from 1 Apr 2018 to 1 May 2019, according to ClinicalTrials.gov record.
- 13 Jul 2015 Planned End Date changed from 1 May 2018 to 1 Apr 2018, according to ClinicalTrials.gov record.